Padam Kafle
#82,973
Most Influential Person Now
Digital Entrepreneur
Padam Kafle's AcademicInfluence.com Rankings
Padam Kaflecomputer-science Degrees
Computer Science
#2773
World Rank
#2903
Historical Rank
Computational Linguistics
#54
World Rank
#56
Historical Rank
Machine Learning
#203
World Rank
#206
Historical Rank
Artificial Intelligence
#349
World Rank
#356
Historical Rank
Download Badge
Computer Science
Padam Kafle's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Padam Kafle Influential?
(Suggest an Edit or Addition)Padam Kafle's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. (2012) (8638)
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection (2000) (3450)
- Extended-Spectrum β-Lactamases: a Clinical Update (2005) (3053)
- Acinetobacter baumannii: Emergence of a Successful Pathogen (2008) (2986)
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study (2010) (2702)
- Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship (2007) (1982)
- Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. (2007) (1306)
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. (2013) (1293)
- Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. (2006) (1205)
- Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. (2011) (708)
- Critical care services and 2009 H1N1 influenza in Australia and New Zealand. (2009) (683)
- Predictors of Mortality in Staphylococcus aureus Bacteremia (2012) (676)
- A Large Outbreak of Clostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use (2005) (659)
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients (2011) (647)
- Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. (2002) (642)
- Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory (2001) (596)
- Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. (2004) (581)
- Aspergillus Infections in Transplant Recipients (2005) (562)
- Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. (1998) (540)
- Community-Acquired Klebsiella pneumoniae Bacteremia: Global Differences in Clinical Patterns (2002) (534)
- Peritoneal Dialysis-Related Infections Recommendations: 2010 Update (2011) (520)
- Adherence to protease inhibitor therapy and outcomes in patients with HIV infection (vol 133, pg 21, 2000) (2002) (512)
- Antimicrobial Resistance in ESKAPE Pathogens (2020) (500)
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens (2012) (492)
- The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. (2012) (490)
- Peritoneal Dialysis-Related Infections Recommendations: 2005 Update (2005) (488)
- Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center (2006) (484)
- Setting and Revising Antibacterial Susceptibility Breakpoints (2007) (483)
- Global dissemination of a multidrug resistant Escherichia coli clone (2014) (480)
- "Collateral damage" from cephalosporin or quinolone antibiotic therapy. (2004) (466)
- Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial (2018) (449)
- Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. (2000) (432)
- Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter (2012) (416)
- International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum -Lactamase Production in Nosocomial Infections (2004) (415)
- Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae (2018) (403)
- Extended-Spectrum β-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type β-Lactamases (2003) (383)
- Invasive aspergillosis in transplant recipients. (1999) (370)
- Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs). (2000) (367)
- The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. (2006) (350)
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. (2017) (347)
- Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. (2007) (342)
- Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned. (2016) (342)
- The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients (2011) (326)
- Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. (2013) (308)
- Antibiotic resistance—What’s dosing got to do with it? (2008) (304)
- Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. (2010) (294)
- The emerging threat of multidrug-resistant Gram-negative bacteria in urology (2015) (293)
- Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii (2007) (272)
- Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. (2006) (271)
- Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States. (2013) (269)
- Therapeutic drug monitoring of antimicrobials. (2012) (265)
- Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007 (2009) (258)
- Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. (2007) (252)
- Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. (2015) (252)
- Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. (2007) (239)
- Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. (2003) (238)
- Carbapenemase-producing Enterobacteriaceae. (2015) (226)
- Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. (2009) (224)
- Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. (2003) (219)
- Augmented Renal Clearance (2010) (211)
- New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn? (2017) (207)
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. (2020) (207)
- Management of meningitis due to antibiotic-resistant Acinetobacter species. (2009) (201)
- In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). (2006) (201)
- Insights into a Multidrug Resistant Escherichia coli Pathogen of the Globally Disseminated ST131 Lineage: Genome Analysis and Virulence Mechanisms (2011) (200)
- A systematic review on clinical benefits of continuous administration of &bgr;-lactam antibiotics* (2009) (199)
- The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. (2006) (198)
- Do human extraintestinal Escherichia coli infections resistant to expanded-spectrum cephalosporins originate from food-producing animals? A systematic review. (2015) (198)
- Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread (2010) (197)
- In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). (2005) (189)
- A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. (2015) (185)
- Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity (2011) (185)
- Aspergillus Galactomannan Antigen in the Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients (2007) (183)
- New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections (2018) (173)
- The Success of Acinetobacter Species; Genetic, Metabolic and Virulence Attributes (2012) (173)
- Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study1 (2003) (172)
- β-Lactamase Production in Key Gram-Negative Pathogen Isolates from the Arabian Peninsula (2013) (170)
- Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. (2011) (169)
- Multiresistant Gram-negative infections: a global perspective (2010) (168)
- Invasive aspergillosis in liver transplant recipients in the 1990s. (1997) (167)
- Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae? (2017) (167)
- Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications (2015) (167)
- Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania (2008) (165)
- Augmented Renal Clearance Implications for Antibacterial Dosing in the Critically Ill (2012) (163)
- Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units. (2013) (162)
- β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options? (2015) (160)
- Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. (2010) (155)
- Th17 cells mediate clade-specific, serotype-independent mucosal immunity. (2011) (154)
- Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates (2010) (152)
- Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea. (2007) (152)
- Antibiotics in the clinical pipeline in October 2019 (2020) (150)
- Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases. (2003) (149)
- Measurement of Adherence to Antiretroviral Medications (2002) (148)
- Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform? (2016) (147)
- Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus. (2000) (146)
- Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly? (2012) (144)
- Simple Disk-Based Method for Detection of Klebsiella pneumoniae Carbapenemase-Type β-Lactamase by Use of a Boronic Acid Compound (2008) (143)
- Redefining extended-spectrum beta-lactamases: balancing science and clinical need. (2008) (143)
- Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli. (2013) (140)
- A step closer to extreme drug resistance (XDR) in gram-negative bacilli. (2007) (138)
- Molecular Characterization of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in the Countries of the Gulf Cooperation Council: Dominance of OXA-48 and NDM Producers (2014) (136)
- Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections. (2016) (135)
- Molecular Epidemiology of CTX-M-Producing Escherichia coli Isolates at a Tertiary Medical Center in Western Pennsylvania (2009) (135)
- Strategies for reduction in duration of antibiotic use in hospitalized patients. (2011) (132)
- Colistin resistance: a major breach in our last line of defence. (2016) (131)
- Infections with Nontyphoidal Salmonella Species Producing TEM-63 or a Novel TEM Enzyme, TEM-131, in South Africa (2004) (131)
- Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients. (2000) (130)
- Dosing Guidance for Intravenous Colistin in Critically Ill Patients (2016) (129)
- Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: A Systematic Review and Meta-analysis (2014) (127)
- A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae (2016) (127)
- Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. (2012) (126)
- Coproduction of Novel 16S rRNA Methylase RmtD and Metallo-β-Lactamase SPM-1 in a Panresistant Pseudomonas aeruginosa Isolate from Brazil (2006) (125)
- Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase. (2011) (124)
- Kucers' the use of antibiotics : a clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs (2017) (122)
- Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient—a review of the literature (2011) (119)
- Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive? (2003) (119)
- Predicting bacteremia and bacteremic mortality in liver transplant recipients (2000) (118)
- Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia. (2006) (117)
- Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. (2007) (116)
- Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial. (2020) (115)
- Uropathogenic Escherichia coli mediated urinary tract infection. (2012) (115)
- Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit. (2008) (114)
- Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance? (2015) (114)
- Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae (2015) (112)
- PREEMPTIVE PROPHYLAXIS WITH A LIPID PREPARATION OF AMPHOTERICIN B FOR INVASIVE FUNGAL INFECTIONS IN LIVER TRANSPLANT RECIPIENTS REQUIRING RENAL REPLACEMENT THERAPY1 (2001) (112)
- Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula (2011) (111)
- Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model (2011) (111)
- Failure of Current Cefepime Breakpoints To Predict Clinical Outcomes of Bacteremia Caused by Gram-Negative Organisms (2007) (110)
- Molecular Epidemiological Analysis of Escherichia coli Sequence Type ST131 (O25:H4) and blaCTX-M-15 among Extended-Spectrum-β-Lactamase-Producing E. coli from the United States, 2000 to 2009 (2012) (110)
- Variation in antifungal prophylaxis strategies in lung transplantation (2006) (110)
- Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study. (2014) (108)
- Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. (1998) (108)
- Extensively Drug-Resistant Acinetobacter baumannii (2009) (108)
- Integron-mediated Multidrug Resistance in a Global Collection of Nontyphoidal Salmonella enterica Isolates (2009) (106)
- Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials (2017) (104)
- Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). (2010) (104)
- Successful Outcome of Human Metapneumovirus (hMPV) Pneumonia in a Lung Transplant Recipient Treated With Intravenous Ribavirin (2007) (104)
- Editorial Response: Extended-Spectrum β-Lactamases: A Call for Improved Detection and Control (1999) (103)
- Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patient. (2009) (103)
- Presence of Plasmid-Mediated Quinolone Resistance in Klebsiella pneumoniae Isolates Possessing blaKPC in the United States (2008) (102)
- Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Isolates in the Gulf Cooperation Council States: Dominance of OXA-23-Type Producers (2015) (102)
- Control of an outbreak of infection due to extended-spectrum beta-lactamase--producing Escherichia coli in a liver transplantation unit. (2001) (101)
- Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy. (2008) (100)
- Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals. (2012) (99)
- Infective endocarditis in solid organ transplant recipients. (1998) (98)
- Interactions between tacrolimus and antimicrobial agents. (1997) (98)
- Resistance in gram-negative bacteria: Enterobacteriaceae. (2006) (95)
- Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. (2011) (95)
- Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study. (2020) (95)
- Epidemiological profile of linezolid-resistant coagulase-negative staphylococci. (2006) (95)
- Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis (2016) (94)
- Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis. (2014) (94)
- Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria (2018) (92)
- Leptospirosis after recreational exposure to water in the Yaeyama islands, Japan. (2005) (92)
- The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model (2012) (92)
- Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection. (1995) (92)
- Outer Membrane Protein Changes and Efflux Pump Expression Together May Confer Resistance to Ertapenem in Enterobacter cloacae (2006) (90)
- CYTOMEGALOVIRUS ANTIGENEMIA DIRECTED PRE-EMPTIVE PROPHYLAXIS WITH ORAL VERSUS I.V. GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN LIVER TRANSPLANT RECIPIENTS1: A Randomized, Controlled Trial (2000) (90)
- Using a theory of planned behaviour framework to explore hand hygiene beliefs at the ‘5 critical moments’ among Australian hospital-based nurses (2015) (89)
- Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance (2012) (88)
- Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: Successful combination therapy with voriconazole and terbinafine (2007) (87)
- Treatment of Infections by OXA-48-Producing Enterobacteriaceae (2018) (86)
- Influenza Vaccine Effectiveness against Hospitalisation with Confirmed Influenza in the 2010–11 Seasons: A Test-negative Observational Study (2013) (85)
- A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae. (2016) (85)
- Health Risks of Flood Disasters (2018) (85)
- Appropriate antimicrobial treatment in nosocomial infections-the clinical challenges. (2003) (84)
- Erratum: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection (Annals of Internal Medicine (2000) 133 (21-30)) (2002) (83)
- What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance. (2012) (83)
- Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study (2017) (82)
- Identification of IncA/C Plasmid Replication and Maintenance Genes and Development of a Plasmid Multilocus Sequence Typing Scheme (2016) (82)
- Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid (2014) (81)
- Bioavailability and Population Pharmacokinetics of Voriconazole in Lung Transplant Recipients (2010) (81)
- Molecular Epidemiology of Multidrug-Resistant Acinetobacter baumannii in a Single Institution over a 10-Year Period (2010) (81)
- Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients (1998) (80)
- Pseudomonas aeruginosa bacteremia over a 10‐year period: multidrug resistance and outcomes in transplant recipients (2009) (79)
- The spread and acquisition of NDM-1: a multifactorial problem (2014) (77)
- Identification of Novel Vaccine Candidates against Multidrug-Resistant Acinetobacter baumannii (2013) (76)
- Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial. (2017) (74)
- The increased risks of death and extra lengths of hospital and ICU stay from hospital-acquired bloodstream infections: a case–control study (2013) (74)
- High prevalence of CTX-M-15-producing Klebsiella pneumoniae among inpatients and outpatients with urinary tract infection in Southern India. (2008) (73)
- Treatment options for New Delhi metallo-beta-lactamase-harboring enterobacteriaceae. (2013) (73)
- An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised trial. (2019) (73)
- A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms. (2006) (72)
- Detection of plasmid-mediated class C β-lactamases (2007) (72)
- Vancomycin Heteroresistance Is Associated with Reduced Mortality in ST239 Methicillin-Resistant Staphylococcus aureus Blood Stream Infections (2011) (72)
- Dominance of IMP-4-Producing Enterobacter cloacae among Carbapenemase-Producing Enterobacteriaceae in Australia (2015) (71)
- Consistent global approach on reporting of colistin doses to promote safe and effective use. (2013) (71)
- Performance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates (2011) (70)
- Diagnosis of Human Metapneumovirus Infection in Immunosuppressed Lung Transplant Recipients and Children Evaluated for Pertussis (2006) (69)
- Cryptococcosis in liver and kidney transplant recipients receiving anti‐thymocyte globulin or alemtuzumab (2007) (69)
- Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol. (2015) (69)
- Dosing Guidance for Intravenous Colistin in Critically Ill Patients. (2016) (68)
- Multiclonal Outbreak of Klebsiella pneumoniae Producing Extended-Spectrum β-Lactamase CTX-M-2 and Novel Variant CTX-M-59 in a Neonatal Intensive Care Unit in Brazil (2008) (68)
- Milligrams per Liter Maintain Troughs between 15 and 20 Associated with Dosing Schedules That Vancomycin-Induced Nephrotoxicity Systematic Review and Meta-Analysis of (2013) (68)
- Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. (2002) (67)
- Looking for risk factors for the acquisition of antibiotic resistance: a 21st-century approach. (2002) (67)
- Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections. (2011) (67)
- Intrapulmonary Penetration of Voriconazole in Patients Receiving an Oral Prophylactic Regimen (2006) (66)
- Identification of 16S rRNA Methylase-Producing Acinetobacter baumannii Clinical Strains in North America (2007) (66)
- Molecular Analysis of the Acinetobacter baumannii Biofilm-Associated Protein (2013) (65)
- Pharmacokinetic evaluation of piperacillin-tazobactam (2010) (65)
- Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF (1999) (64)
- Genomic Characteristics of NDM-Producing Enterobacteriaceae Isolates in Australia and Their blaNDM Genetic Contexts (2015) (64)
- Lack of efficacy of mupirocin in the prevention of infections with staphylococcus aureus in liver transplant recipients and candidates1 (2003) (63)
- A role for human cytomegalovirus glycoprotein O (gO) in cell fusion and a new hypervariable locus. (2002) (62)
- Cost-Effectiveness of a Central Venous Catheter Care Bundle (2010) (62)
- In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). (2009) (62)
- Pediatric Visceral Leishmaniasis in Western Sicily, Italy: A Retrospective Analysis of 111 Cases (2002) (61)
- Aerosol Deposition of Lipid Complex Amphotericin‐B (Abelcet) in Lung Transplant Recipients (2006) (61)
- Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial (2015) (61)
- Extended-spectrum beta-lactamases: the European experience (2001) (61)
- Clinical experience with recently approved antibiotics. (2006) (61)
- Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study. (2020) (60)
- High Prevalence of Metallo-β-Lactamase and 16S rRNA Methylase Coproduction among Imipenem-Resistant Pseudomonas aeruginosa Isolates in Brazil (2007) (60)
- Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media. (2013) (59)
- Secure placement of peritoneal dialysis catheters using a laparoscopic technique. (1996) (59)
- Expression and dynamic modulation of the human granulocyte colony‐stimulating factor receptor in immature and differentiated myeloid cells (1993) (58)
- OqxAB, a Quinolone and Olaquindox Efflux Pump, Is Widely Distributed among Multidrug-Resistant Klebsiella pneumoniae Isolates of Human Origin (2013) (57)
- Vancomycin therapeutics and monitoring: a contemporary approach (2013) (56)
- Risk factors for toxicity in elderly patients given aminoglycosides once daily (1998) (56)
- SHV-Type Extended-Spectrum Beta-Lactamase Production Is Associated with Reduced Cefepime Susceptibility in Enterobacter cloacae (2005) (56)
- Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil. (1998) (56)
- Determination of Risk Factors Associated With Isolation of Linezolid-Resistant Strains of Vancomycin-Resistant Enterococcus (2007) (55)
- Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns. (2011) (54)
- Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Burns Patients—A One-Year Prospective Study (2012) (54)
- Pulmonary Nodules in Liver Transplant Recipients (1997) (54)
- CAMERA2 – combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial (2016) (54)
- Community-acquired extended-spectrum beta-lactamase producers, United States. (2007) (54)
- Effect of Parenteral Antibiotic Administration on Establishment of Intestinal Colonization in Mice by Klebsiella pneumoniae Strains Producing Extended-Spectrum β-Lactamases (2003) (54)
- Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae (2015) (54)
- Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill Patients (2017) (54)
- Cost-Effectiveness of a National Initiative to Improve Hand Hygiene Compliance Using the Outcome of Healthcare Associated Staphylococcus aureus Bacteraemia (2016) (53)
- Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection: A Collaborative Analysis of Individual Patient Data From 14 Studies (2017) (53)
- Spread of MCR-3 Colistin Resistance in China: An Epidemiological, Genomic and Mechanistic Study (2018) (53)
- COVID-19—Lessons Learned and Questions Remaining (2020) (52)
- Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli. (2009) (51)
- Activity of Temocillin against KPC-Producing Klebsiella pneumoniae and Escherichia coli (2009) (51)
- Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients. (2008) (51)
- Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27 (2018) (51)
- Prolonged carriage of resistant E. coli by returned travellers: clonality, risk factors and bacterial characteristics (2012) (50)
- New clinical presentations of invasive aspergillosis in non-conventional hosts. (2004) (50)
- Challenges for Standardization of Clostridium difficile Typing Methods (2013) (50)
- Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients (2011) (49)
- Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. (2021) (49)
- Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum &bgr;-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort (2017) (49)
- Characterization of a Naturally Occurring Class D β-Lactamase from Achromobacter xylosoxidans (2008) (49)
- Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision (2009) (48)
- Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy (2001) (48)
- Antimicrobial treatment challenges in the era of carbapenem resistance. (2019) (48)
- Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial (2021) (48)
- Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition. (2017) (48)
- Extended-spectrum beta-lactamase-producing Klebsiella spp. in a neonatal intensive care unit: risk factors for the infection and the dynamics of the molecular epidemiology (2007) (48)
- Effect of the Increasing Use of Piperacillin/Tazobactam on the Incidence of Vancomycin-Resistant Enterococci in Four Academic Medical Centers (2004) (48)
- Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14. (2015) (47)
- Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases. (2012) (47)
- Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study. (2011) (47)
- Putting back the bugs: bacterial treatment relieves chronic diarrhoea (1994) (47)
- Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment. (1998) (47)
- Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2. (2010) (47)
- Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion. (2006) (46)
- Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs, seventh edition (2017) (46)
- Optimizing therapy for infections caused by enterobacteriaceae producing extended-spectrum beta-lactamases. (2007) (46)
- Control of an Outbreak of Carbapenem-Resistant Acinetobacter baumannii in Australia after Introduction of Environmental Cleaning with a Commercial Oxidizing Disinfectant (2010) (46)
- Multihospital Occurrence of Pan-Resistant Klebsiella pneumoniae Sequence Type 147 with an ISEcp1-Directed blaOXA-181 Insertion in the mgrB Gene in the United Arab Emirates (2017) (46)
- Clostridium difficile Infection Seasonality: Patterns across Hemispheres and Continents – A Systematic Review (2015) (46)
- Mechanisms of hypervirulent Clostridium difficile ribotype 027 displacement of endemic strains: an epidemiological model (2015) (46)
- Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study. (2016) (45)
- Detection of plasmid-mediated class C beta-lactamases. (2007) (45)
- Genotypic and phenotypic identification of Aeromonas species and CphA-mediated carbapenem resistance in Queensland, Australia. (2016) (45)
- Multidrug-Resistant Bacteria in the Community: An Update. (2020) (45)
- Characterisation of clinical and food animal Escherichia coli isolates producing CTX-M-15 extended-spectrum β-lactamase belonging to ST410 phylogroup A. (2011) (44)
- Molecular Epidemiology and Mechanisms of Carbapenem Resistance of Acinetobacter spp. in Asia and Oceania. (2015) (44)
- Hospital-wide Eradication of a Nosocomial Legionella pneumophila Serogroup 1 Outbreak. (2016) (44)
- Extended-spectrum beta-lactamases: a call for improved detection and control. (1999) (44)
- Intrapulmonary Disposition of Amphotericin B After Aerosolized Delivery of Amphotericin B Lipid Complex (Abelcet; ABLC) in Lung Transplant Recipients (2010) (44)
- Ampicillin/sulbactam: its potential use in treating infections in critically ill patients. (2013) (44)
- Characterization of an IncN2-type blaNDM-₁-carrying plasmid in Escherichia coli ST131 and Klebsiella pneumoniae ST11 and ST15 isolates in Thailand. (2014) (44)
- Listeriosis in patients receiving biologic therapies (2013) (44)
- Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model (2013) (44)
- Expansive spread of IncI1 plasmids carrying blaCMY-2 amongst Escherichia coli. (2014) (43)
- Health care-associated pneumonia: identification and initial management in the ED. (2008) (43)
- Characteristics of bloodstream infections in burn patients: An 11-year retrospective study. (2012) (43)
- Discovery of mcr-1-Mediated Colistin Resistance in a Highly Virulent Escherichia coli Lineage (2018) (43)
- Surgical site infections following coronary artery bypass graft procedures: 10 years of surveillance data (2014) (43)
- Voriconazole Pharmacokinetics in Liver Transplant Recipients (2009) (42)
- Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients. (2008) (42)
- Quality of life in long‐term survivors after liver transplantation: impact of recurrent viral hepatitis C virus hepatitis 1 (2000) (42)
- Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis. (2016) (42)
- Restrictive antibiotic policies are appropriate in intensive care units (2003) (41)
- Escherichia coli ST131 producing CTX-M-15 in Australia. (2010) (41)
- Achromobacter Infections and Treatment Options (2020) (41)
- Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae (2018) (41)
- Rapid method of extraction and analysis of extended-spectrum beta-lactamases from clinical strains of Klebsiella pneumoniae. (2001) (41)
- Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis. (1999) (41)
- Faecal carriage of CTX-M-15-producing Klebsiella pneumoniae in patients with acute gastroenteritis. (2009) (40)
- Draft Genome Sequence of NDM-5-Producing Escherichia coli Sequence Type 648 and Genetic Context of blaNDM-5 in Australia (2015) (40)
- New Gram-positive antibiotics: better than vancomycin? (2011) (40)
- Mechanisms Involved in Acquisition of blaNDM Genes by IncA/C2 and IncFIIY Plasmids (2016) (40)
- CTX-M-2-producing Salmonella Typhimurium isolated from pediatric patients and poultry in Brazil. (2009) (40)
- Antimicrobial chemotherapy and lung microdialysis: a review. (2010) (39)
- Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient. (1999) (39)
- Identification of carbapenem‐resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high‐risk clones in the region (2018) (39)
- Multidrug‐resistant Acinetobacter: a threat to the antibiotic era (2006) (39)
- Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved? (2007) (39)
- A New Marker of Sepsis Post Burn Injury?* (2014) (38)
- Reduced susceptibility of Staphylococcus aureus to vancomycin--a review of current knowledge. (1999) (37)
- Long-term morbidity and mortality following bloodstream infection: A systematic literature review. (2018) (36)
- Multidrug-resistant Escherichia coli in Asia: epidemiology and management (2015) (36)
- A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III. (2019) (36)
- Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials (2021) (36)
- Assessing control bundles for Clostridium difficile: a review and mathematical model (2014) (36)
- Economic rationale for infection control in Australian hospitals (2009) (36)
- Clinical Characteristics of Bloodstream Infections Due to Ampicillin-Sulbactam-Resistant, Non-Extended- Spectrum-β-Lactamase-Producing Escherichia coli and the Role of TEM-1 Hyperproduction (2010) (36)
- Zoonotic disease in Australia caused by a novel member of the paramyxoviridae. (1998) (35)
- Dynamics of mcr-1 prevalence and mcr-1-positive Escherichia coli after the cessation of colistin use as a feed additive for animals in China: a prospective cross-sectional and whole genome sequencing-based molecular epidemiological study. (2020) (35)
- Molecular Epidemiology of NDM-1-Producing Enterobacteriaceae and Acinetobacter baumannii Isolates from Pakistan (2014) (35)
- The Potential Role of Social Media Platforms in Community Awareness of Antibiotic Use in the Gulf Cooperation Council States: Luxury or Necessity? (2015) (35)
- Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae? (2004) (35)
- Genetic Contexts of blaNDM-1 in Patients Carrying Multiple NDM-Producing Strains (2015) (34)
- First Case of Bloodstream Infection Caused by Rhodococcus erythropolis (2009) (34)
- Enhanced diagnosis of pandemic (H1N1) 2009 influenza infection using molecular and serological testing in intensive care unit patients with suspected influenza. (2010) (34)
- In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends). (2006) (34)
- Facing the challenge of multidrug‐resistant gram‐negative bacilli in Australia (2015) (34)
- Human cytomegalovirus glycoprotein H/glycoprotein L complex modulates fusion-from-without. (1998) (33)
- Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002-2010. (2013) (33)
- Enhancement of antibiotic-activity through complexation with metal ions - Combined ITC, NMR, enzymatic and biological studies. (2017) (33)
- Modifications in the pmrB gene are the primary mechanism for the development of chromosomally encoded resistance to polymyxins in uropathogenic Escherichia coli (2017) (33)
- Community-Onset Escherichia coli Infection Resistant to Expanded-Spectrum Cephalosporins in Low-Prevalence Countries (2014) (33)
- How soon is now? The urgent need for randomized, controlled trials evaluating treatment of multidrug-resistant bacterial infection. (2010) (33)
- Returning to the pre-antibiotic era in the critically ill: the XDR problem. (2007) (32)
- Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae. (2018) (32)
- Serious infections caused by enteric gram-negative bacilli--mechanisms of antibiotic resistance and implications for therapy of gram-negative sepsis in the transplanted patient. (2002) (32)
- Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling. (2016) (31)
- Meropenem Administered as a Prolonged Infusion to Treat Serious Gram‐Negative Central Nervous System Infections (2004) (31)
- Redefining extended-spectrum β-lactamases: balancing science and clinical need—authors’ response (2009) (31)
- Dynamics of mcr-1 prevalence and mcr-1-positive Escherichia coli after the cessation of colistin use as a feed additive for animals in China: a prospective cross-sectional and whole genome sequencing based molecular epidemiological study (2020) (31)
- Acquisition of Rectal Colonization by Vancomycin-Resistant Enterococcus among Intensive Care Unit Patients Treated with Piperacillin-Tazobactam versus Those Receiving Cefepime-Containing Antibiotic Regimens (2007) (31)
- Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand. (2011) (31)
- Central nervous system nocardiosis in Queensland (2016) (31)
- A survey of antibiotic prescribing practices in Australian and New Zealand intensive care units. (2010) (30)
- Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-&bgr;-lactamase-producing Enterobacteriaceae (2017) (30)
- New treatment options for multiresistant gram negatives. (2020) (30)
- Antimicrobial stewardship activities: a survey of Queensland hospitals. (2013) (30)
- Novel Integron Gene Cassette Arrays Identified in a Global Collection of Multi-Drug Resistant Non-Typhoidal Salmonellaenterica (2010) (29)
- Researching effective approaches to cleaning in hospitals: protocol of the REACH study, a multi-site stepped-wedge randomised trial (2015) (29)
- Transmission of mcr-1-Producing Multidrug-resistant Enterobacteriaceae in Public Transportation in Guangzhou, China. (2018) (29)
- Fracture-related infection: current methods for prevention and treatment (2020) (28)
- Reduced Susceptibility to Cefepime among Escherichia coli Clinical Isolates Producing Novel Variants of CMY-2 β-Lactamase (2009) (28)
- Interaction of daptomycin with two recombinant thromboplastin reagents leads to falsely prolonged patient prothrombin time/International Normalized Ratio results (2008) (28)
- Replacement of healthcare-associated MRSA by community-associated MRSA in Queensland: confirmation by genotyping. (2013) (28)
- Intraoperative hypothermia is an independent risk factor for early cytomegalovirus infection in liver transplant recipients. (1998) (28)
- Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents (2020) (28)
- Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei (2019) (28)
- Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy. (2013) (27)
- Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model (2017) (27)
- Genomic Investigation Reveals Contaminated Detergent as the Source of an Extended-Spectrum-β-Lactamase-Producing Klebsiella michiganensis Outbreak in a Neonatal Unit (2020) (27)
- Reducing the development of antibiotic resistance in critical care units. (2011) (27)
- Indinavir-associated hepatitis in patients with advanced HIV infection (1998) (26)
- Prevalence of NDM‐1 carbapenemase in patients with diarrhoea in Pakistan and evaluation of two chromogenic culture media (2013) (26)
- Changes in knowledge and attitudes of hospital environmental services staff: The Researching Effective Approaches to Cleaning in Hospitals (REACH) study (2018) (26)
- Escherichia coli Isolate Coproducing 16S rRNA Methylase and CTX-M-Type Extended-Spectrum β-Lactamase Isolated from an Outpatient in the United States (2008) (25)
- Long-term mortality following Pseudomonas aeruginosa bloodstream infection. (2017) (25)
- Copper Ions and Coordination Complexes as Novel Carbapenem Adjuvants (2017) (25)
- Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis (2021) (25)
- Carriage of an ACME II Variant May Have Contributed to Methicillin-Resistant Staphylococcus aureus Sequence Type 239-Like Strain Replacement in Liverpool Hospital, Sydney, Australia (2012) (25)
- Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2) (2021) (25)
- Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis (2020) (25)
- Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012-2014: prospective, repeated cross-sectional study. (2017) (25)
- Increases in Australian cutaneous abscess hospitalisations: 1999–2008 (2011) (24)
- Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities (2016) (24)
- Pharmacokinetics of beta-lactam antibiotics in patients with intra-abdominal disease: a structured review. (2012) (24)
- Evaluation of a new chromogenic medium, chromID OXA-48, for recovery of carbapenemase-producing Enterobacteriaceae from patients at a university hospital in Turkey (2015) (24)
- Simkania Negevensis in Bronchoalveolar Lavage of Lung Transplant Recipients: A Possible Association with Acute Rejection (2007) (24)
- Molecular Analysis of the Simultaneous Production of Two SHV-Type Extended-Spectrum Beta-Lactamases in a Clinical Isolate of Enterobacter cloacae by Using Single-Nucleotide Polymorphism Genotyping (2005) (24)
- Risk factors for mortality among patients with Pseudomonas aeruginosa bacteremia - retrospective multicenter study. (2019) (23)
- Surveillance snapshot of Clostridium difficile infection in hospitals across Queensland detects binary toxin producing ribotype UK 244. (2014) (23)
- Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis. (2007) (23)
- Interspecies Transfer of bla IMP-4 in a Patient with Prolonged Colonization by IMP-4-Producing Enterobacteriaceae (2014) (23)
- Gram‐negative resistance: can we combat the coming of a new “Red Plague”? (2013) (22)
- Laboratory-based surveillance of Clostridium difficile circulating in Australia, September - November 2010. (2016) (22)
- A population-based spatio-temporal analysis of Clostridium difficile infection in Queensland, Australia over a 10-year period. (2014) (22)
- A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study. (2013) (22)
- Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case–control study (2017) (22)
- Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains. (2013) (22)
- Clinical Characteristics, Etiology, and Initial Management Strategy of Newly Diagnosed Periprosthetic Joint Infection: A Multicenter, Prospective Observational Cohort Study of 783 Patients (2020) (22)
- Community-associated Methicillin-resistant Staphylococcus aureus Causing Orbital Cellulitis in Australian Children (2011) (21)
- Has the time come for routine trimethoprim-sulfamethoxazole prophylaxis in patients taking biologic therapies? (2013) (21)
- Pulmonary fungal infections (2005) (21)
- Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections. (2020) (21)
- Multiplex PCR to detect the genes encoding naturally occurring oxacillinases in Acinetobacter spp. (2014) (21)
- Return to sender: the need to re‐address patient antibiotic allergy labels in Australia and New Zealand (2016) (21)
- 25-Hydroxyvitamin D Concentrations and Clostridium difficile Infection: A Meta-Analysis (2017) (21)
- Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae (2019) (21)
- Species identification within Acinetobacter calcoaceticus-baumannii complex using MALDI-TOF MS. (2015) (21)
- An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa. (2020) (20)
- Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand. (2015) (20)
- Changing epidemiology of meticillin-resistant S. aureus in Queensland, Australia, 2000-2006: use of passive surveillance of susceptibility phenotypes. (2008) (20)
- Editorial commentary: the new Acinetobacter equation: hypervirulence plus antibiotic resistance equals big trouble. (2015) (20)
- A Case of IMP-4-, OXA-421-, OXA-96-, and CARB-2-Producing Acinetobacter pittii Sequence Type 119 in Australia (2014) (20)
- Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae (2015) (20)
- Disseminated donovanosis (granuloma inguinale) causing spinal cord compression: case report and review of donovanosis involving bone. (1998) (20)
- Emergence of bla(OXA-181)-carrying ColE plasmid in Klebsiella pneumoniae in Australia. (2013) (20)
- Benzylpenicillin versus flucloxacillin for penicillin susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study. (2019) (19)
- Tuberculosis in the Australian Indigenous population: history, current situation and future challenges (2011) (19)
- Epidemiology of non-multiresistant methicillin-resistant Staphylococcus aureus infection in Queensland, Australia: associations with indigenous populations and Panton–Valentine leukocidin (2010) (19)
- 16S ribosomal RNA methylase RmtD produced by Klebsiella pneumoniae in Brazil. (2008) (19)
- Changes in Healthcare-Associated Staphylococcus aureus Bloodstream Infections after the Introduction of a National Hand Hygiene Initiative (2014) (19)
- Mycobacterium mucogenicum bacteremia in a patient with cirrhosis. (1998) (18)
- Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia. (2019) (18)
- Cryptococcus neoformans infection (2002) (18)
- Treatment Options for Chronic Prostatitis due to Vancomycin-Resistant Enterococcus faecium (1998) (18)
- Antimicrobial stewardship - Roundtable discussion (2006) (18)
- Understanding the determinants of Australian hospital nurses' hand hygiene decisions following the implementation of a national hand hygiene initiative. (2015) (17)
- Comparative Genomics and Antimicrobial Resistance Profiling of Elizabethkingia Isolates Reveal Nosocomial Transmission and In Vitro Susceptibility to Fluoroquinolones, Tetracyclines, and Trimethoprim-Sulfamethoxazole (2020) (17)
- CAMERA 2 – combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection : study protocol for a randomised controlled trial (2017) (17)
- Should third‐generation cephalosporins be the empirical treatment of choice for severe community‐acquired pneumonia in adults? (1998) (17)
- Antimicrobial resistance prevention initiative: Proceedings of an expert panel on resistance - Roundtable discussion (2006) (17)
- The role of surveillance cultures in the prediction of susceptibility patterns of Gram-negative bacilli in the intensive care unit (2011) (17)
- Genetic Environment of 16S rRNA Methylase Gene rmtD (2008) (17)
- Culture independent detection systems for bloodstream infection. (2021) (17)
- Influenza‐associated bacterial pathogens in patients with 2009 influenza A (H1N1) infection: impact of community‐associated methicillin‐resistant Staphylococcus aureus in Queensland, Australia (2012) (17)
- Cutibacterium (Proprionibacterium) acnes in Shoulder Surgery: a Scoping Review of Strategies for Prevention, Diagnosis and Treatment. (2020) (17)
- Adherence to Protease Inhibitors (2001) (17)
- KPC Type β-Lactamase, Rural Pennsylvania (2006) (17)
- Variation in Hospital Cleaning Practice and Process in Australian Hospitals: A Structured Mapping Exercise (2017) (17)
- Outbreaks of multidrug-resistant Acinetobacter baumannii strains in a Kenyan teaching hospital. (2014) (16)
- Comprehensive analysis of type 1 fimbriae regulation in fimB‐null strains from the multidrug resistant Escherichia coli ST131 clone (2016) (16)
- All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies (2021) (16)
- Is inhaled prophylactic heparin useful for prevention and Management of Pneumonia in ventilated ICU patients?: The IPHIVAP investigators of the Australian and New Zealand Intensive Care Society Clinical Trials Group. (2016) (16)
- Monitoring of serum aminoglycoside levels with once‐daily dosing (1998) (16)
- Multidrug-Resistant Gram-Negative Pathogens: The Urgent Need for 'Old' Polymyxins. (2019) (16)
- Risk factors for urinary catheter associated bloodstream infection. (2015) (15)
- Severe Pneumonia and Human Bocavirus in Adult (2006) (15)
- The use of SWATH to analyse the dynamic changes of bacterial proteome of carbapanemase-producing Escherichia coli under antibiotic pressure (2018) (15)
- Piroxicam induced submassive necrosis of the liver. (1992) (15)
- Cost-effectiveness of an Environmental Cleaning Bundle for Reducing Healthcare-associated Infections (2019) (15)
- Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution (2020) (15)
- Isolation of vancomycin-resistant enterococci in Queensland, case 1 (1996) (15)
- Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection - a multi-site retrospective study. (2020) (15)
- Genomic analysis of carbapenemase-producing Enterobacteriaceae in Queensland reveals widespread transmission of bla IMP-4 on an IncHI2 plasmid (2019) (15)
- Budget impact analysis of routinely using whole-genomic sequencing of six multidrug-resistant bacterial pathogens in Queensland, Australia (2021) (15)
- Review of the epidemiological data regarding antimicrobial resistance in Gram-negative bacteria in Australia (2017) (14)
- Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae (2019) (14)
- Pre-medication practices and incidence of infusion-related reactions in patients receiving AMPHOTEC: data from the Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) registry. (2008) (14)
- Introduction: Serious Infections in the Intensive Care Unit: Pseudomonas aeruginosa and Acinetobacter baumannii (2006) (14)
- Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care (2021) (14)
- Evaluation of the SpeeDx Carba (beta) multiplex real-time PCR assay for detection of NDM, KPC, OXA-48-like, IMP-4-like and VIM carbapenemase genes (2019) (14)
- Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trial (2017) (14)
- Kucers' The Use of Antibiotics (2010) (13)
- Increased risk of death with recurrent Pseudomonas aeruginosa bacteremia. (2017) (13)
- Clinical spectrum of urinary tract infections due to nontyphoidal Salmonella species. (1997) (13)
- Legionellosis and biologic therapies. (2014) (13)
- Comprehensive analysis of IncC plasmid conjugation identifies a crucial role for the transcriptional regulator AcaB (2020) (13)
- Determining research priorities for clinician‐initiated trials in infectious diseases (2013) (12)
- How urgent is the need for new antifungals? (2021) (12)
- In situ probing the interior of single bacterial cells at nanometer scale (2014) (12)
- Is Ceftazidime/Avibactam an Option for Serious Infections Due to Extended-Spectrum-β-Lactamase- and AmpC-Producing Enterobacterales?: a Systematic Review and Meta-analysis (2020) (12)
- Rapidly fatal bacteremia due to Staphylococcus aureus producing both enterotoxins A and B in a liver transplant recipient. (1997) (12)
- Meropenem-Vaborbactam vs. Best Available Therapy for Carbapenem-Resistant Enterobacteriaceae Infections in TANGO II: Outcomes in Immunocompromised Patients (2017) (12)
- Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi‐year, multicenter prospective cohort study (2018) (12)
- INTERNATIONAL PRASPECTIVE STUDY OF KLEBSIELLA PNEUMONIAE IN NOSOCOMIAL BACTEREMIA:IMPLICATIONS OF EXTENDEDSPECTERUM- BETA LACTAMASE PRODUCTION IN NOSOCOMIAL INFECTIONS (2004) (12)
- PME-1-Producing Pseudomonas aeruginosa in Qatar (2015) (12)
- China's antibiotic resistance problems. (2017) (12)
- Spontaneous Gram-Negative Cellulitis in a Liver Transplant Recipient (2001) (12)
- A prospective registry of emergency department patients admitted with infection (2011) (12)
- Transmission of Bacterial Infections to Healthcare Workers during Intubation and Respiratory Care of Patients with Severe Pneumonia (2009) (12)
- Key beliefs of hospital nurses' hand-hygiene behaviour: protecting your peers and needing effective reminders. (2015) (11)
- Serious infections due to Staphylococcus lugdunensis. (1997) (11)
- Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study. (2021) (11)
- Is inhaled prophylactic heparin useful for prevention and management of pneumonia in ventilated ICU patients? (2016) (11)
- Exacerbated Hyperglycemia Associated with Nelfinavir (1998) (11)
- Culture‐independent detection of chlorhexidine resistance genes qacA/B and smr in bacterial DNA recovered from body sites treated with chlorhexidine‐containing dressings (2016) (11)
- Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling (2018) (11)
- CYTOMEGALOVIRUS ANTIGENEMIA DIRECTED PRE-EMPTIVE PROPHYLAXIS WITH ORAL VERSUS I.V. GANCICLOVIR FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN LIVER TRANSPLANT RECIPIENTS 1 (2000) (10)
- Mechanisms of resistance of bacteria causing ventilator-associated pneumonia. (2005) (10)
- P. aeruginosa blood stream infection isolates: A "full house" of virulence genes in isolates associated with rapid patient death and patient survival. (2018) (10)
- Prior statin use is not associated with improved outcome in emergency patients admitted with infection: a prospective observational study. (2011) (10)
- Vancomycin-resistant Staphylococcus aureus (1999) (10)
- Fatal respiratory diphtheria caused by β-lactam-resistant Corynebacterium diphtheriae. (2020) (10)
- Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients (2019) (10)
- Rectal colonization with New Delhi metallo-β-lactamase-1-producing Escherichia coli prior to transrectal ultrasound (TRUS)-guided prostate biopsy. (2013) (10)
- More Evidence of the Benefits of Rational Antimicrobial Use in Clinical Practice (2003) (10)
- PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales (2021) (9)
- Changes in healthcare-associated infections after the introduction of a national hand hygiene initiative (2014) (9)
- Draft Genome Sequences of Two IMP-4-Producing Escherichia coli Sequence Type 131 Isolates in Australia (2015) (9)
- Evaluation of Meropenem‐Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal Clearance (2021) (9)
- pneumoniae Bacteremia: Global Differences in Clinical Patterns (2002) (9)
- Synergy of the Polymyxin-Chloramphenicol Combination against New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae Is Predominately Driven by Chloramphenicol. (2021) (9)
- Incidence of community onset MRSA in Australia: least reported where it is Most prevalent (2019) (9)
- Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicol. (2020) (9)
- Clinical Features and Molecular Epidemiology of CMY-Type β -Lactamase-Producing Escherichia coli (2009) (9)
- Central nervous system nocardiosis in Queensland: A report of 20 cases and review of the literature. (2016) (9)
- External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteremia cohort: The prognostic significance of colistin resistance. (2019) (9)
- Molecular Comparison of Bacterial Communities on Peripheral Intravenous Catheters and Matched Skin Swabs (2016) (9)
- Burkholderia pseudomallei Clinical Isolates Are Highly Susceptible In Vitro to Cefiderocol, a Siderophore Cephalosporin (2020) (9)
- Antimicrobial susceptibility reporting and treatment selection for AmpC-producing Enterobacteriaceae: what do microbiologists and infectious disease practitioners actually practice? (2015) (9)
- General Practitioner Antimicrobial Stewardship Programme Study (GAPS): protocol for a cluster randomised controlled trial (2016) (8)
- An UHPLC-MS/MS method for the simultaneous determination of ampicillin and sulbactam in human plasma and urine. (2015) (8)
- Modifying antibiotic prescribing in primary care. (2006) (8)
- Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBL-E): a systematic review and meta-analysis. (2021) (8)
- Antimicrobial-impregnated central venous catheters. (1999) (8)
- Multicentre randomised double-blind placebo controlled trial of combination vancomycin and cefazolin surgical antibiotic prophylaxis: the Australian surgical antibiotic prophylaxis (ASAP) trial (2019) (8)
- Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study. (2017) (8)
- Emergence of novel bla(KPC-13) among carbapenem-resistant Enterobacteriaceae in Thailand. (2014) (8)
- Antibiotic-resistant infections in the critically ill adult. (2004) (7)
- Infections due to other members of the enterobacteriaceae, including management of multidrug-resistant strains (2011) (7)
- Treatment of ESBL producers (2007) (7)
- The Use of Therapeutic Drug Monitoring to Optimize Treatment of Carbapenem-Resistant Enterobacter Osteomyelitis. (2015) (7)
- Detection of carbapenemase activity in Enterobacteriaceae using LC-MS/MS in comparison with the neo-rapid CARB kit using direct visual assessment and colorimetry. (2016) (7)
- Predictors of Treatment Success After Periprosthetic Joint Infection: 24-Month Follow up From a Multicenter Prospective Observational Cohort Study of 653 Patients (2022) (7)
- Could a herpesvirus mimic tacrolimus‐induced leukoencephalopathy? (1997) (7)
- Active surveillance for multidrug-resistant Gram-negative bacteria in the intensive care unit (2015) (7)
- Community-Acquired Clostridium difficile Infection, Queensland, Australia (2016) (7)
- Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection (2022) (7)
- Antibiotic‐induced antimicrobial resistance in Aeromonas spp. (1997) (7)
- Rapid detection of NDM and VIM carbapenemase encoding genes by recombinase polymerase amplification and lateral flow–based detection (2021) (7)
- Multi-drug-resistant Gram-negative bacteria (2013) (7)
- Clinical and Economic Outcomes of Genome Sequencing Availability on Containing a Hospital Outbreak of Resistant Escherichia coli in Australia. (2020) (6)
- Guideline of guidelines: management of recurrent urinary tract infections in women (2022) (6)
- Local acquisition and nosocomial transmission of Klebsiella pneumoniae harbouring the blaNDM‐1 gene in Australia (2015) (6)
- Differentiation of Acinetobacter Genomic Species 13BJ/14TU from Acinetobacter haemolyticus by Use of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry (MALDI-TOF MS) (2015) (6)
- Nanoscale Focused Ion Beam Tomography of Single Bacterial Cells for Assessment of Antibiotic Effects (2014) (6)
- A hierarchical spatial modelling approach to investigate MRSA transmission in a tertiary hospital (2013) (6)
- Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting (2022) (6)
- MicroPIPE: validating an end-to-end workflow for high-quality complete bacterial genome construction (2021) (6)
- Number of missed doses: why 1 × 7 does not make 7 × 1? (2012) (6)
- Predictors of use of infection control precautions for multiresistant gram-negative bacilli in Australian hospitals: analysis of a national survey. (2014) (6)
- Outcomes with Cefiderocol Treatment in Patients with Bacteraemia Enrolled into Prospective Phase 2 and Phase 3 Randomised Clinical Studies (2022) (6)
- Fosfomycin: what was old is new again (2018) (6)
- Trends and Lessons Learned (2016) (6)
- Clinical Features and Molecular Epidemiology of CMY-Type b-Lactamase – Producing Escherichia coli (2009) (6)
- Draft Genome Sequence of an IMP-7-Producing Pseudomonas aeruginosa Bloodstream Infection Isolate from Australia (2017) (5)
- Appropriate pharmacokinetic index for outcome in Staphylococcus aureus pneumonia. (2007) (5)
- Skin colonization at peripheral intravenous catheter insertion sites increases the risk of catheter colonization and infection. (2019) (5)
- Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasis. (2009) (5)
- Evaluating the economics of the Australian National Hand Hygiene Initiative (2012) (5)
- Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales (“MERINO-3”): study protocol for a multicentre, open-label randomised non-inferiority trial (2021) (5)
- Antimicrobial therapy for Pseudomonas aeruginosa - Therapeutic issues; resistance; pneumonia; endocarditis; and infections of the GI tract, bone and joint, and urinary tract (1998) (5)
- The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe (2022) (5)
- Molecular epidemiology of Pseudomonas aeruginosa bloodstream infection isolates in a non‐outbreak setting (2017) (5)
- Evaluation of phenotypic screening tests for carbapenemase production in Pseudomonas aeruginosa from patients with cystic fibrosis. (2015) (5)
- Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131 (2021) (5)
- The molecular epidemiology of extended-spectrum beta-lactamase producing organisms. (2008) (5)
- Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial (2022) (5)
- Intensive infection control responses and whole genome sequencing to interrupt and resolve widespread transmission of OXA-181 Escherichia coli in a hospital setting (2019) (4)
- Do staffing and workload levels influence the risk of new acquisitions of meticillin-resistant Staphylococcus aureus in a well-resourced intensive care unit? (2012) (4)
- Short versus standard course intravenous antibiotics for peri-prosthetic joint infections managed with debridement and implant retention: a randomised pilot trial using a desirability of outcome ranking (DOOR) endpoint. (2022) (4)
- Efficacy and Safety of Carbapenems vs New Antibiotics for Treatment of Adult Patients With Complicated Urinary Tract Infections: A Systematic Review and Meta-analysis (2020) (4)
- Critically-Ill Patients from a Multi-Center Study Provide Dosing Suggestions for Various (2011) (4)
- Antibiotics for Ceftriaxone Resistant Gram-Negative Bacterial Bloodstream Infections-Reply. (2019) (4)
- Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae, Northeast Florida (2009) (4)
- Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli. (2018) (4)
- Infectious complications at six months in lung transplant recipients undergoing pretransplant T-cell depletion (2004) (4)
- A multilevel model of methicillin-resistant Staphylococcus aureus acquisition within the hierarchy of an Australian tertiary hospital. (2012) (4)
- Clinical implementation of routine whole-genome sequencing for hospital infection control of multi-drug resistant pathogens (2022) (4)
- Genomic investigation of an outbreak of carbapenemase-producing Enterobacter cloacae: long-read sequencing reveals the context of blaIMP4 on a widely distributed IncHI2 plasmid (2017) (4)
- Pasteurella species bloodstream infections in Queensland, Australia, 2000–2019 (2022) (4)
- For peer review only The increased risks of death and extra lengths of hospital and ICU stay from hospital-acquired bloodstream infections: a case-control study (2013) (4)
- 1316. Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol in Critically Ill Patients (2020) (4)
- A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to Gram negative pathogens. Intended category: systematic review. (2021) (4)
- Standard rectal swabs as a surrogate sample for gut microbiome monitoring in intensive care (2022) (4)
- Community-acquired Pseudomonas aeruginosa bloodstream infection: a classification that should not falsely reassure the clinician (2017) (4)
- The risk of resistance: what are the major antimicrobial resistance threats facing Australia? (2019) (4)
- Clostridium Difficile Diarrhoea Associated with Chemotherapy for Ovarian Cancer (1997) (4)
- Acute Myocardial Infarction and Community-Acquired Staphylococcus aureus Bloodstream Infection: an observational cohort study. (2020) (4)
- The Challenge of Treating Superbugs (2015) (4)
- Evaluation of quick sequential organ failure assessment and systemic inflammatory response syndrome in patients with gram negative bloodstream infection. (2020) (4)
- Predominance of VREfm ST203 subgroup in Queensland. (2013) (3)
- Morganella morganii, an Emerging Cause of Bloodstream Infections (2022) (3)
- Carriage Duration and Household Transmission of Enterobacterales Producing Extended-Spectrum Beta-Lactamase in the Community: A Systematic Review and Meta-Analysis. (2022) (3)
- Efficacy of CMV antigeemia directed preemptive therapy with ganciclovir at one year in liver transplant recipients pretreated with thymoglobulin or alemtuzumab (2004) (3)
- Re-activation of varicella zoster virus associated with anterior spinal cord stroke in pregnancy (2016) (3)
- Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study (2023) (3)
- Genomic investigation reveals contaminated detergent as the source of an ESBL-producing Klebsiella michiganensis outbreak in a neonatal unit (2019) (3)
- Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality. (2022) (3)
- Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial. (2022) (3)
- Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study (2022) (3)
- Diagnosis of urinary tract infection in older persons in the emergency department: To pee or not to pee, that is the question (2019) (3)
- The epidemiology of pan/extreme drug resistance (2012) (3)
- Adverse clinical outcomes associated with carbapenem-resistant Acinetobacter (CRA) infections: a systematic review and meta-analysis (2021) (3)
- Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review (2022) (3)
- Pseudomonas aeruginosa blood stream infection isolates from patients with recurrent blood stream infection: Is it the same genotype? (2017) (3)
- Linezolid: the first oxazolidinone antimicrobial. (2003) (3)
- MicroPIPE: An end-to-end solution for high-quality complete bacterial genome construction (2021) (3)
- Reporting of pre-enrolment screening with randomized clinical trials: A small item that could impact a big difference (2015) (3)
- Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections (2022) (3)
- The molecular epidemiology of Pseudomonas aeruginosa bloodstream infection isolates in a non-outbreak setting. (2016) (3)
- Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial (2021) (3)
- Th17 cells mediate clade specific mucosal immunity (2012) (3)
- High level aminoglycoside resistance in enterococcal blood culture isolates (1996) (3)
- Antimicrobial therapy for Pseudomonas aeruginosa - Skin and soft tissue, ear, and eye infections, meningitis, and clinical syndromes of febrile neutropenic and HIV patients (1998) (3)
- Performance of the BioFire Blood Culture Identification 2 panel for the diagnosis of bloodstream infections (2022) (3)
- Strain and lineage-level methylome heterogeneity in the multi-drug resistant pathogenic Escherichia coli ST101 clone (2020) (3)
- Combination therapy for bloodstream infections with carbapenemase-producing Enterobacteriaceae - Authors' reply. (2017) (2)
- Reply to “Vancomycin-Induced Nephrotoxicity” (2013) (2)
- PP-034 Jolt accentuation of headache in diagnosis of acute meningitis (2010) (2)
- Post-discharge surgical site surveillance - where to from here? (2013) (2)
- Impact of various infectious syndromes on the immune function profile in lung transplant recipients (2007) (2)
- Optimising Treatment Outcomes for Children and Adults Through Rapid Genome Sequencing of Sepsis Pathogens. A Study Protocol for a Prospective, Multi-Centre Trial (DIRECT) (2021) (2)
- CO‐MRSA Infections in Australia Cost $3.5B Per Annum (2017) (2)
- Dominance of ST131 Escherichia coli carrying blaCTX-M in patients with bloodstream infections caused by cephalosporin-resistant strains in Australia, New Zealand and Singapore: whole genome analysis of isolates from a randomised trial (2017) (2)
- Combination antibiotic therapy for Pseudomonas aeruginosa bacteremia in febrile neutropenic patients? The question still remains (2018) (2)
- Multiclonal Outbreak of Klebsiella pneumoniae Producing Extended-Spectrum (cid:2) -Lactamase CTX-M-2 and Novel Variant CTX-M-59 in a Neonatal Intensive Care Unit in Brazil (cid:1) (2008) (2)
- Effect of a Selective Decontamination of the Digestive Tract Regimen Including Parenteral Cefepime on Establishment of Intestinal Colonization with Vancomycin-Resistant Enterococcus spp. and Klebsiella pneumoniae in Mice (2006) (2)
- A role for Human cytomegalovirus glycoprotein gO in mediating celluar fusion and a new hypervariable locus (2002) (2)
- Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria (2022) (2)
- Response of Renal Transplant Recipients to the Monovalent Pandemic H1N1 Vaccine (2011) (2)
- Characteristics and outcomes of culture-negative prosthetic joint infections from the Prosthetic Joint Infection in Australia and New Zealand Observational (PIANO) cohort study. (2022) (2)
- Bacterial identification using an Absciex 5800 TOF/TOF MALDI research instrument and an external database. (2019) (2)
- Reply to Falagas and Karageorgopoulos (2008) (2)
- Reply to Corona and Cattaneo. (2017) (2)
- Optimizing Antimicrobial Therapy for Serious Infections in the Critically Ill (2007) (2)
- Japanese Encephalitis Outbreak, Yuncheng, China, (2007) (2)
- Proposed empiric antibiotic therapy for prosthetic joint infections: an analysis of the Prosthetic Joint Infection in Australia and New Zealand, Observational (PIANO) cohort (2022) (2)
- Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia. (2018) (2)
- Maximizing Therapeutic Success in an Era of Increasing Antibiotic Drug Resistance (2006) (2)
- A Snapshot about the Mobile Colistin Resistance (mcr) in The Middle East and North Africa Region (2019) (2)
- Intrapulmonary penetration of voriconazole in lung transplant patients (2005) (2)
- Infection control implications of extended-spectrum beta-lactamase (ESBL) production by Klebsiellae and other Gram-negative bacteria (2001) (2)
- Genomic characterisation and context of the blaNDM-1 carbapenemase in Escherichia coli ST101 (2019) (1)
- Genomic surveillance, characterisation and intervention of a carbapenem-resistant Acinetobacter baumannii outbreak in critical care (2020) (1)
- Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility. (2022) (1)
- Erratum to “Is inhaled prophylactic heparin useful for prevention and management of pneumonia in ventilated ICU patients? The IPHIVAP investigators of the Australian and New Zealand Intensive Care Society Clinical Trials Group” Journal of Critical Care 34 (2016) 95–102 (2016) (1)
- Population Pharmacokinetics Analysis of Amikacin Initial Dosing Regimen in Elderly Patients (2021) (1)
- Burkholderia pseudomallei clinical isolates are highly susceptible in vitro to cefiderocol, a novel siderophore cephalosporin (2020) (1)
- Achromobacter Species: An Emerging Cause of Community-Onset Bloodstream Infections (2022) (1)
- Cefoxitin, Cefotetan and Other Cephamycins (Cefmetazole and Flomoxef) (2010) (1)
- Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection Model (2021) (1)
- Ceftizoxime, cefdinir, cefditoren, cefpodoxime, ceftibuten, cefsulodin, and cefpiramide (2017) (1)
- Infections in the Immunocompromised Patient (2011) (1)
- Gram-Negative Neonatal Sepsis in Low- and Middle- Income Countries: How Appropriate are the WHO Recommended Empirical Sepsis Antibiotic Regimens? A Systematic Review and Meta-Analysis (2021) (1)
- Clinical Burkholderia pseudomallei isolates from north Queensland carry diverse bimABm genes that are associated with central nervous system disease and are phylogenomically distinct from other Australian strains (2021) (1)
- Doubtful model utility in predicting high vancomycin minimum inhibitory concentration methicillin-resistant Staphylococcus aureus bloodstream infection episodes. (2011) (1)
- Latest perspectives on antibiotic use in the community (2006) (1)
- GENOTYPIC AND PHENOTYPIC IDENTIFICATION OF AEROMONAS SPECIES AND CARBAPENEM RESISTANCE IN QUEENSLAND, AUSTRALIA (2015) (1)
- Relative infrequency of microsporidial infection in HIV infected patients in Queensland (1994) (1)
- Cellulitis caused by a multidrug‐resistant group A streptococcus (1996) (1)
- Photo quiz. Subcutaneous abscess due to Mycobacterium abscessus. (1998) (1)
- In Vitro Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial (2021) (1)
- Bacterial Sub-Species Typing Using Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry: What Is Promising? (2021) (1)
- Diagnosis: Subcutaneous abscess due to Mycobacterium abscessus (1998) (1)
- Multi-drug Resistant Enterobacteriaceae from Bhutan: Whole Genome Sequencing of ESBL and Carbapenemase-producing Strains (2016) (1)
- Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial (2022) (1)
- Optimized Method for Bacterial Nucleic Acid Extraction from Positive Blood Culture Broth for Whole-Genome Sequencing, Resistance Phenotype Prediction, and Downstream Molecular Applications (2022) (1)
- Characteristics of community-acquired carbapenem-resistant Enterobacterales. (2022) (1)
- Pharmacokinetics-Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: a Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents (2020) (1)
- Comparative genomics and antimicrobial resistance profiling of Elizabethkingia isolates reveals nosocomial transmission and in vitro susceptibility to fluoroquinolones, tetracyclines and trimethoprim-sulfamethoxazole (2020) (1)
- Draft Genome Sequences of Two Pseudomonas aeruginosa Bloodstream Infection Isolates Associated with Rapid Patient Death (2017) (1)
- Infectious Diseases: A Clinical Approach, 2nd Edition (2006) (1)
- Completing the Picture - Capturing the Resistome in Antibiotic Clinical Trials. (2020) (1)
- Modern clinician-initiated clinical trials to determine optimal therapy for multi-drug resistant Gram-negative infections. (2019) (1)
- Glycerol and Bacterial Meningitis: A Response to the Editorial Commentary by Sa´ez-Llorens and McCracken (2010) (1)
- Molecular Epidemiology of Carbapenem Non-Susceptible Acinetobacter baumannii Isolates From the Gulf Cooperation Council States (2013) (1)
- Infections with Organisms Producing Extended-Spectrum β-Lactamase (2010) (1)
- Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis (2021) (1)
- An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa--authors' response. (2021) (1)
- 486Meropenem and Piperacillin-tazobactam have Comparable Outcomes in Treatment of Bloodstream Infections Caused by Extended Spectrum Beta-lactamase Producing E.coli and Klebsiellae (2014) (1)
- The implementation and impact of an interdisciplinary antibiotic management program (2005) (1)
- Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies (2022) (1)
- Measuring patient centred long term outcome following a bloodstream infection: a pilot study. (2020) (1)
- Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial (2021) (1)
- Features of plasmids carrying blaNDM-1 and blaNDM-3 in Australia (2011) (1)
- Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria (2018) (1)
- Cost-effectiveness analysis of whole-genome sequencing during an outbreak of carbapenem-resistant Acinetobacter baumannii (2021) (1)
- Principles of antimicrobial use (2017) (1)
- P663 Worldwide antimicrobial susceptibility patterns among E. coli isolated from intra-abdominal infections (IAI): results from SMART 2005 (2007) (1)
- Letter From Australia: A Never-Ending Pandemic? (2021) (1)
- Variable exposure to fixed-dose voriconazole in liver transplant recipients (2008) (1)
- Molecular Characterization of Multidrug-Resistant Gram-negative Bacilli in Egypt: A Snapshot Study (2019) (1)
- Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile , 2013 – 14 (2015) (1)
- COMPARISON OF PHENOTYPIC METHODS FOR THE DETECTION OF IMP PRODUCING ENTEROBACTERIACEAE IN QUEENSLAND (2014) (1)
- Reply to Bonten and Mevius. (2015) (0)
- Extended Spectrum Beta-lactamases in Gram-negative Sepsis (2002) (0)
- Resistance Trends ( SMART ) Program , 2007 the Study for Monitoring Antimicrobial fromBacilli in the Asia-Pacific Region : Data-Lactamase-Producing Gram-Negative β Extended-Spectrum-Emergence of High Levels of (2009) (0)
- Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates. (2022) (0)
- Antimicrobial Susceptibility Rates among Gram-negative Bacilli Isolated From Intraabdominal Infections in the United States: SMART 2005 Results (2006) (0)
- Extended-spectrum beta-lactamase producing bacteria : epidemioloyg, characterisation, detection and treatment (2004) (0)
- Pulmonary infiltrates in a neutropenic host (1999) (0)
- Clinical Characteristics of Bloodstream Infections Due to Ampicillin-Sulbactam-Resistant, Non-Extended-Spectrum- (cid:1) -Lactamase-Producing Escherichia coli and the Role of TEM-1 Hyperproduction (cid:1) (2011) (0)
- Reply to Soman et al. (2013) (0)
- Multi-hospital spread of a pan-resistant Klebsiella pneumoniae clone with an ISEcp1-directed blaOXA-181 insertion into the mgrB gene in the AE (2016) (0)
- Matrix-Assisted Laser Desorption Ionization Mass Spectrometer (MALDI-TOF MS) based Antibiotic Susceptibility Testing (2019) (0)
- Preliminary results of the Organ Transplant Infection Project (OTIP), a multi-year cohort study of stem cell and lung transplant recipients (2008) (0)
- Molecular Characterization of Carbapenem Resistant Pseudomonas aeruginosa in the Arabian Peninsula (2015) (0)
- Management of Infections in Living-Donor Transplant Recipients (2007) (0)
- Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model (2022) (0)
- Predicting bacteremia and mortality in bacteremic liver transplant recipients (1999) (0)
- Extended Spectrum Beta-Iactamases in Gram-negative Sepsis (2002) (0)
- Discussion: A correlation between WT1 expression levels and known risk factors for early relapse is demonstrated. In the minimal residual disease setting, detectable WT1 levels in peripheral blood post-induction and post-consolidation pre- dicted very poor leukaemia free survival. CARCINOGENIC EFFEC (2010) (0)
- ICE volume 36 issue 2 Cover and Front matter (2015) (0)
- Prospective evaluation of beta-lactamase detection in penicillin susceptible Staphylococcus aureus by interpretation of the penicillin disc edge (2019) (0)
- Duration of antibiotic treatment and timing of oral switch for bloodstream infections: a survey on the practices of infectious diseases and intensive care physicians. (2023) (0)
- Mastering resistant bacteria using whole genome sequencing (2018) (0)
- β-Lactam–Resistant Streptococcus pneumoniae Dynamics Following Treatment: A Dose-Response Meta-analysis (2022) (0)
- Regimens Superiority of Combination Antimicrobial KPC-Producing Klebsiella pneumoniae : Treatment Outcome of Bacteremia Due to (0)
- OP-JACR210013 1..3 (2021) (0)
- Th17 cells mediate clade specific mucosal immunity (49.26) (2012) (0)
- Anticoagulation and Antiplatelet Strategies in Non-Critically Ill Patients with Covid-19 (2022) (0)
- SRA Down Under: Cache and Analysis Platform for Infectious Disease. (2019) (0)
- 76. “Gadgets and gizmos aplenty!” Dressing and securing peripherally inserted central catheters to prevent infection and failure (2022) (0)
- The next generation – the use of whole genome sequencing in outbreak management and HAI (2021) (0)
- 229. Molecular and Clinical Epidemiology of Carbapenemase-Producing E. coli Isolates from Different Global Regions (CRACKLE-2) (2022) (0)
- Session:202-Global Health and Parasitology and Travel Medicine (2011) (0)
- 673. Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA): Results from a multi-national, multicenter observational study (2022) (0)
- Does baseline prevalence or targeted prophylaxis reduce infectious complications after prostate biopsy? A bias-adjusted meta-analysis (2014) (0)
- Impact of Changing Transplantation Practices and Conditioning Regimens on the Epidemiology of Transplant Related Infections: Solid Organ Transplantation (2004) (0)
- Burkholderia pseudomallei isolates from Queensland carry diverse 1 bimA Bm genes that are associated with central nervous system disease and 2 are phylogenomically distinct from other Australian strains 3 4 (2021) (0)
- A role for glycoprotien gO in mediating cellular fusion of beta herpes viruses (2001) (0)
- Evaluation of a new chromogenic medium, chromID OXA-48, for recovery of carbapenemase-producing Enterobacteriaceae from patients at a university hospital in Turkey (2014) (0)
- Implications of Antimicrobial Use on the Spread of the Newer Beta-Lactamases (2008) (0)
- Long term sepsis readmission, mortality and cause of death following Gram negative bloodstream infection: a propensity matched observational linkage study. (2021) (0)
- Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae (2015) (0)
- A contemporary case series of Pseudomonas aeruginosa infective endocarditis (2023) (0)
- Colonization with non-Aspergillus molds is not associated with the occurrence of invasive disease in lung transplant recipients. (2007) (0)
- Reply to Bonten and Mevius : Less Evidence for an Important Role of Food-Producing Animals as Source of Antibiotic Resistance in Humans (2015) (0)
- Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case–control study (2017) (0)
- For and Against Routine Removal of Peripheral Intravenous Catheters. (2022) (0)
- Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution (2020) (0)
- Rapid and sensitive molecular detection of antimicrobial resistance (AMR); towards point-of-care testing in low resource settings (2020) (0)
- Diagnosing sepsis in the ICU: Comparison of a gene expression signature to pre-existing biomarkers. (2023) (0)
- A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections (2022) (0)
- Clostridioides difficile infection: clinical practice and health outcomes in six large tertiary hospitals in Eastern Australia (2023) (0)
- Social media platforms for raising awareness of appropriate antibiotics use in the Gulf Cooperation Council states (2015) (0)
- Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study. (2022) (0)
- Editorial: Spotlight on the Relationship Between Sepsis and Infection: From Mechanisms to Therapy (2021) (0)
- Evolving insights into the epidemiology of Moraxella species bloodstream infection from two decades of surveillance in Queensland, Australia (2023) (0)
- Standard rectal swabs as a surrogate sample for gut microbiome monitoring in intensive care (2022) (0)
- Aminoglycoside use in the elderly in the era of once daily dosing (1997) (0)
- Simkania negevensis infection and acute rejection in lung transplant recipient (2006) (0)
- Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria (2023) (0)
- Resistance phenotype prediction from whole genome sequencing data in ESBL or plasmid-AmpC-producing E. coli or K. pneumoniae: results from bloodstream isolates collected during an international multicentre randomized trial (2016) (0)
- An Australian perspective on antimicrobial stewardship programs and transplantation (2022) (0)
- Determinants and outcomes of bloodstream infections related to obesity (2022) (0)
- Incidence and predictors of Escherichia coli producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia from 2010 to 2019: a population-based spatial analysis (2022) (0)
- A desirability of outcome ranking (DOOR) for periprosthetic joint infection - a Delphi analysis. (2022) (0)
- A multimodal intervention to optimise antimicrobial use in residential aged care facilities (ENGAGEMENT): protocol for a stepped-wedge cluster randomised trial (2022) (0)
- Treatment of severe meningitis due to antibiotic‐resistant Streptococcus pneumoniae (1999) (0)
- Population-Based Incidence and Characteristics of Adult Escherichia coli Bloodstream Infection in Queensland, Australia, From 2000 to 2019 (2023) (0)
- Cefotiam, Cefuzonam, Cefamandole, Cefonicid and Ceforanide (2010) (0)
- 451: Epidemiology of late bacterial pneumonia in a prospective cohort of lung transplant recipients (LTRs) (2007) (0)
- Systematic benchmarking of ‘all-in-one’ microbial SNP calling pipelines (2022) (0)
- Clinical quiz: Cellulitis in a liver transplant recipient (2001) (0)
- Contributors (2012) (0)
- Cefadroxil, cephaloridine, cephacetrile, cephapirin, cephradine, and other rarely used first-generation cephalosporins (2017) (0)
- MicroPIPE: validating an end-to-end workflow for high-quality complete bacterial genome construction (2021) (0)
- How Far Away is the Arabian Peninsula from the Storm Caused by "Carbapenem Resistant Gram-Negative Bacilli?" (2012) (0)
- Prevalence of imp type metallo-β-lactamase in carbapenem resistant pseudomonas aeruginosa and correlation of genotype to phenotype (2012) (0)
- Prolonged gastrointestinal carriage of antimicrobial-resistant Escherichia coli in international travellers (2011) (0)
- Five cases of infection with the dematiaceous fungus, Coniothyrium fuckelii (1997) (0)
- Editorial: Infections in the intensive care unit - important questions remain (2007) (0)
- Reply to buckley and shakib (1999) (0)
- Travelling with Friends: NDM-1 and other resistance genes (2011) (0)
- Human herpesvirus 6 infection in organ transplant recipients (1998) (0)
- Broad spectrum ß-lactamase producing Gram-negative bacilli (GNB) in the Gulf Cooperation Council (GCC) states - "The known known and the known unknown" (2011) (0)
- Repository General Practitioner Antimicrobial Stewardship Programme Study ( GAPS ) : Protocol for a cluster randomised controlled trial (2016) (0)
- Infection profile in lung transplant recipients associated with suppressed T cell reactivity (2006) (0)
- COULD A HERPESVIRUS MIMIC TACROLIMUS-INDUCED LEUKOENCEPHALOPATHY? AUTHORS'REPLY (1997) (0)
- High prevalence of ArmA-16S rRNA methyltransferase among aminoglycoside-resistant Klebsiella pneumoniae bloodstream isolates. (2022) (0)
- SG-APSIC1073: Incidence and predictors of Escherichia coli–producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia, from 2010 to 2019: A population-based spatial analysis (2023) (0)
- Next Generation Antibiotic Susciptability Testing (Ngast): The Potential Use of Matrix-Assisted Laser Desorption Ionization Mass Spectrometer as a Tool for Rapid Antibiotic Susceptibility Testing (2019) (0)
- Respiratory Infections in Immunocompromised Non-Neutropenic Patients (2001) (0)
- Significant clinical differences but not outcomes between Klebsiella aerogenes and Enterobacter cloacae bloodstream infections: a comparative cohort study. (2023) (0)
- Infectious complications at one year in lung retransplant recipients (LRTRs): A matcbed case control study (2007) (0)
- Erratum to: Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections. (2020) (0)
- Reply to Rezahosseini and Nielsen. (2020) (0)
- Next-Generation Polymyxin Class of Antibiotics: A Ray of Hope Illuminating a Dark Road (2022) (0)
- Prolonged carriage of resistant E. coli by returned travellers: clonality, risk factors and bacterial characteristics (2012) (0)
- Treatment of ESBL producers (Enfermedades Infecciosas y Microbiologia Clinica (2007) 25, SUPPL. 2, (60-63)) (2008) (0)
- Infections caused by gram-positive bacteria in liver transplant recipients: Present situation and challenges (2007) (0)
- Demographics and Patient Details for Patients both With and Without Sepsis (2014) (0)
- Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections (2023) (0)
- Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center (cid:1) (2006) (0)
- Imipenem-cilastatin and imipenem-relebactam (2017) (0)
- Community-acquired Pseudomonas aeruginosa bloodstream infection: a classification that should not falsely reassure the clinician (2016) (0)
- Harmonica player's "hemoptysis". (1992) (0)
- The Accuracy of Combined Disk Assay to Screen for Metallo-ß- Lactamases in Carbapenem Resistant Acinetobacter baumannii (2014) (0)
- INFLUENCE OF HEPATITIS C VIRUS (HCV) RECURRENCE ON QUALITY OF LIFE (QOL) OF LONG-TERM LIVER TRANSPLANT SURVIVORS. (1999) (0)
- BK Virus Nephropathy (2000) (0)
- Cefaclor, cefprozil, and loracarbef (2017) (0)
- Community-acquired infections with stenotrophomonas maltophilia (1997) (0)
- Shewanella spp. Bloodstream Infections in Queensland, Australia (2022) (0)
- 1612. Evaluation of the Use of Ceftolozane/Tazobactam for the Treatment of ESBL-producing Enterobacterales Infections Using International Data from SPECTRA (Study of Prescribing Patterns and Effectiveness of Ceftolozane/Tazobactam Real World Analysis) (2020) (0)
- Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections. (2022) (0)
- Antimicrobial Resistance in Organ Transplant Recipients (2001) (0)
- The use of SWATH to analyse the dynamic changes of bacterial proteome of carbapanemase-producing Escherichia coli under antibiotic pressure (2018) (0)
- Chapter 5 The clinical success of Acinetobacter species ; genetic metabolic and virulence attributes (2012) (0)
- Plasmid-mediated AmpC-like beta-lactamases - They're coming from everywhere! (2000) (0)
- P712 Risk factors for Nocardia infection in organ transplant recip-ients: a matched case-control study over an 11-year period (2007) (0)
- Sion, and Four Sets of Cultures of Blood Obtained during the Hospitaliza- Endocarditis with Resolution of Symptoms. given the Polymicrobial Although Mycobacterial Infection of Permanent Indwelling Catheters (2010) (0)
- Emergence of novel mutations of caspofungin resistance in candida glabrata with prolonged therapy (2010) (0)
- Burden and Future Gram-Negative Resistance in Asia/Australia (2008) (0)
- Infectious complications at six months in lung transplant recipients undergoing pretranspnat T-cell depletion with alemtuzumab (2005) (0)
- Discordance between comparable Pseudomonas aeruginosa antibiogram susceptibilities and pharmacodynamic target attainment rates: Importance of the MIC distribution. (2005) (0)
- Erratum: Antimicrobial therapy for Pseudomonas aeruginosa: Therapeutic issues; resistance, pneumonia; endocarditis; and infections of the GI tract, bone and joint, and urinary tract (Infections in Medicine (1995) 20 (302- 308)) (1998) (0)
- Brain Abscesses in Liver Transplant Recipients: Prospective, Multicenter Study with Implications for Management. (1998) (0)
- Reducing amphotericin B toxicity and cost (1999) (0)
- baumannii Biofilm-Associated Protein Molecular Analysis of the Acinetobacter (2013) (0)
- Biopatch™ or Kendall™ AMD foam disc to reduce the incidence of central-line-associated blood stream infection: A feasibility study (2016) (0)
- Factors that may contribute in increasing the prevalence of broad spectrum ß-lactamase producers among Gram-negative bacilli in the Gulf Cooperation Council (GCC) states (2011) (0)
- Determining the in vitro susceptibility of tebipenem, an oral carbapenem, against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolated from bloodstream infections (2022) (0)
- Increases in Australian cutaneous abscess hospitalisations: 1999–2008 (2011) (0)
- Researching Effective Approaches to Cleaning in Hospitals (REACH) (2014) (0)
- Acute Viral Syndromes (2011) (0)
- Mapping the global prevalence of resistance to antimicrobials in gram-negative urinary pathogens: a meta-analysis of contemporary studies (2016) (0)
- Evaluation of levofloxacin 750 mg pharmacodynamic, target attainment rates in organisms causing nosocomial pneumonia at an academic medical center with comparisons to surveillance data for Pseudomonas aeruginosa (2004) (0)
- Title: Identification of a novel MCR-1 variant displaying low level of co-resistance to β-lactam (2023) (0)
- Premedication Practices and Incidence of Infusion-related Reactions in Patients Receiving AMPHOTEC: Data from the PRoACT-Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (2008) (0)
- Diagnosing Sepsis in the Intensive Care Unit: A Retrospective Cohort Study (2020) (0)
- Global spread of multidrug-resistant gram-negative bacilli (2010) (0)
- Infectious perils of transplantation (1999) (0)
- Incidence of community onset MRSA in Australia: least reported where it is Most prevalent (2019) (0)
- 2279. Study of Prescribing patterns and Effectiveness of Ceftolozane–tazobactam (C/T): Real-world Analysis (SPECTRA): a multi-national, multicenter observational study (2019) (0)
- Therapeutic drug monitoring [3] (multiple letters) (1997) (0)
- Iconographies supplémentaires de l'article : Do staffing and workload levels influence the risk of new acquisitions of meticillin-resistant Staphylococcus aureus in a well-resourced intensive care unit? (2012) (0)
- PP-224 Tuberculous meningitis in adults: review of 22 cases (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Padam Kafle?
Padam Kafle is affiliated with the following schools:
